Abstract:BACKGROUND:Whole-exome sequencing can provide insight into the relationship between observed clinical phenotypes and underlying genotypes. METHODS:We conducted a retrospective analysis of data from a series of 7374 consecutive unrelated patients who had been referred to a clinical diagnostic laboratory for whole-exome sequencing; our goal was to determine the frequency and clinical characteristics of patients for whom more than one molecular diagnosis was reported. The phenotypic similarity between molecularly diagnosed pairs of diseases was calculated with the use of terms from the Human Phenotype Ontology. RESULTS:A molecular diagnosis was rendered for 2076 of 7374 patients (28.2%); among these patients, 101 (4.9%) had diagnoses that involved two or more disease loci. We also analyzed parental samples, when available, and found that de novo variants accounted for 67.8% (61 of 90) of pathogenic variants in autosomal dominant disease genes and 51.7% (15 of 29) of pathogenic variants in X-linked disease genes; both variants were de novo in 44.7% (17 of 38) of patients with two monoallelic variants. Causal copy-number variants were found in 12 patients (11.9%) with multiple diagnoses. Phenotypic similarity scores were significantly lower among patients in whom the phenotype resulted from two distinct mendelian disorders that affected different organ systems (50 patients) than among patients with disorders that had overlapping phenotypic features (30 patients) (median score, 0.21 vs. 0.36; P=1.77×10-7). CONCLUSIONS:In our study, we found multiple molecular diagnoses in 4.9% of cases in which whole-exome sequencing was informative. Our results show that structured clinical ontologies can be used to determine the degree of overlap between two mendelian diseases in the same patient; the diseases can be distinct or overlapping. Distinct disease phenotypes affect different organ systems, whereas overlapping disease phenotypes are more likely to be caused by two genes encoding proteins that interact within the same pathway. (Funded by the National Institutes of Health and the Ting Tsung and Wei Fong Chao Foundation.).

Analysis of phenotype-genotype connection: the story of dissecting disease pathogenesis in genomic era in China, and beyond.

Analysis of Phenotype–genotype Connection: the Story of Dissecting Disease Pathogenesis in Genomic Era in China, and Beyond

[A consensus on the standardization of the next generation sequencing process for the diagnosis of genetic diseases (3) - Data analysis].

From Phenotype to Gene: Detecting Disease-Specific Gene Functional Modules Via A Text-Based Human Disease Phenotype Network Construction

Advances in Genetics of Complex Disease

[Whole-genome sequencing: a new approach for understanding of pathogenesis and individualized treatment of cancer].

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

New-generation high-throughput technologies based 'omics' research strategy in human disease]

A comprehensive repository of mutation data and a clinical assistant decision system for hemoglobinopathy in the Chinese population

Systems medicine: the future of medical genomics and healthcare

Human Phenome based on traditional Chinese medicine--a solution to congenital syndromology

Mapping and Identification of Disease Responsible Genes Based on Genetic Resource Reservation and Bioinformatics Approach.

A brief history of human disease genetics

Optimization Methods for Genotype Data Analysis in Epidemiological Studies

Genome-wide genotype-phenotype associations in microbes

[Chinese Human Genome Project--opportunity and Challenge].

Whole Genome Analyses of Chinese Population and De Novo Assembly of A Northern Han Genome

Exploring noncoding variants in genetic diseases: From detection to functional insights

Bedside Back to Bench: Building Bridges between Basic and Clinical Genomic Research

Strategies and Methods to Identify Genes for Complex Diseases

Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation.